发明名称 Use of adenosine for the manufacture of medicaments for continuous intravenous infusion to human patients.
摘要 <p>Adenosine is administered to humans by continuous intravenous infusion at levels at which the heart blocking action of adenosine is not detected, to modify the hemodynamic properties of the patient. Specific indications of use are effecting preferential coronary vasodilation, increasing blood flow in a coronary artery graft and increasing cardiac output.</p>
申请公布号 EP0506205(A1) 申请公布日期 1992.09.30
申请号 EP19920201323 申请日期 1985.10.29
申请人 SOLLMEDCO AKTIEBOLAG 发明人 SOLLEVI, ALF
分类号 C07H19/167;A61K31/70;A61K31/7042;A61K31/7052;A61K31/7076;A61P9/08;A61P9/10;A61P9/12;C07H19/16 主分类号 C07H19/167
代理机构 代理人
主权项
地址